background image

Paid Clinical Trials Montana

Discover 244 paid clinical trials in Montana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Missoula MT, West Jordan UT, Denver CO, Bellingham WAshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

TTVR Early Feasibility Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Missoula MT, Portland OR, Minneapolis MN, San Francisco CAshow 15 more

Code:

NCT04433065

Conditions

Tricuspid Regurgitation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intrepidâ„¢ TTVR System

Group Telehealth Behavioral Cough Suppression Therapy

Recruiting
EARLY_PHASE1

Sponsor:

University of Montana

Location:

Missoula MT

Code:

NCT06706765

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Behavioral Treatment

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Missoula MT, Twin Falls ID, Boise ID, Meridian IDshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Kalispell MT, Saskatoon, Minot ND, Fort Collins COshow 77 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Bozeman MT, Billings MT, Anaconda MTshow 109 more

Code:

NCT05111574

Conditions

Anal Melanoma

Bladder Melanoma

Cervical Melanoma

Esophageal Melanoma

Gallbladder Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Testing the Addition of Immunotherapy Before Surgery for Patients with Sarcomatoid Mesothelioma

Recruiting
PHASE2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Missoula MT, Twin Falls ID, Boise ID, Meridian IDshow 65 more

Code:

NCT05647265

Conditions

Pleural Biphasic Mesothelioma

Pleural Sarcomatoid Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Ipilimumab

Surgical Procedure

Computed Tomography

Magnetic Resonance Imaging

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Bozeman MT, Kalispell MT, Nampa IDshow 101 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Recruiting
PHASE2
PHASE3

Sponsor:

Inhibrx Biosciences, Inc

Location:

Billings MT, Portland OR, Las Vegas NV, Sacramento CAshow 18 more

Code:

NCT06295731

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INBRX-106

Pembrolizumab

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Helena MT, Bozeman MT, Billings MTshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Popular cities in Montana